Streamline Health Solutions (NASDAQ:STRM) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report published on Monday. The brokerage issued a sell rating on the stock.

Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a strong-buy rating in a research note on Thursday, September 5th.

Streamline Health Solutions Price Performance

Streamline Health Solutions stock opened at $0.21 on Monday. The stock has a market cap of $13.24 million, a P/E ratio of -0.67 and a beta of 1.62. The company has a fifty day simple moving average of $0.44 and a 200-day simple moving average of $0.43. Streamline Health Solutions has a 12-month low of $0.14 and a 12-month high of $1.00. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings results on Wednesday, September 11th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.01). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The company had revenue of $4.48 million for the quarter.

Institutional Trading of Streamline Health Solutions

A hedge fund recently bought a new stake in Streamline Health Solutions stock. Mesirow Financial Investment Management Inc. acquired a new stake in Streamline Health Solutions, Inc. (NASDAQ:STRM) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 123,900 shares of the company’s stock, valued at approximately $59,000. Mesirow Financial Investment Management Inc. owned about 0.21% of Streamline Health Solutions at the end of the most recent reporting period. Institutional investors and hedge funds own 31.74% of the company’s stock.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.